Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Edwards Lifesciences Corporation (EW) Cash Flow from Investing Activities data is not available for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$6.07B |
|
$1.07B |
|
$1.33B |
|
$4.73B |
|
$4.80B |
|
$1.26B |
|
$8.70M |
|
$1.27B |
|
$1.42B |
|
$1.06B |
|
$1.06B |
|
$1.07B |
|
$1.23B |
|
$1.26B |
|
$1.26B |
|
584.80M |
|
585.80M |
|
$1.84 |
|
$1.83 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
|
Cash Flow from Investing Activities |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|